Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival

NCT01574170 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

267

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer Starting a Third Line Chemotherapy

Interventions

OTHER: Construction of a prognostic score (non-drug intervention types)

Sponsor

Institut Claudius Regaud